Design, synthesis and biological evaluation of novel N-napthyl-5-aryl-1,3,4-thiadiazol-2-amine derivatives as anticancer and their molecular docking studies
Organic Communications · 25.08.2026 · 19 (3)
DOI: 10.25135/org.2606.3946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Communications, online erschienen am 25.08.2026. Verfasst von Prashant Rameshwarrao Yawale und 3 weiteren Autor:innen.
Abstract (Originalsprache)
A novel series of N-napthyl-5-aryl-1,3,4-thiadiazol-2-amine derivatives have been synthesized from naphthyl-thiosemicarbazide and carboxylic acids using intermolecular cyclization under acidic condition. The newly synthesized compounds have been characterized by IR, 1H, 13C NMR and mass spectral studies. All the synthesized compounds subjected to comprehensive analysis of their in vitro anticancer against human prostate carcinoma cell line (PC-3). Amongst, compound 3d exhibited prominent cytotoxicity activity towards prostate cancer cell line (PC-3 cell: IC50 = 26.95 ± 0.06 μM), comparable to doxorubicin. Our finding provides a new structure of thiadiazole having promising potential in anticancer drug development program.
Zitieren
APA
Yawale, P. R., Humne, V. T., Jadhao, N. L., & Thakare, N. R. (2026). Design, synthesis and biological evaluation of novel N-napthyl-5-aryl-1,3,4-thiadiazol-2-amine derivatives as anticancer and their molecular docking studies. Organic Communications, 19(3). https://doi.org/10.25135/org.2606.3946
Vancouver
Yawale PR, Humne VT, Jadhao NL, Thakare NR. Design, synthesis and biological evaluation of novel N-napthyl-5-aryl-1,3,4-thiadiazol-2-amine derivatives as anticancer and their molecular docking studies. Organic Communications. 2026;19(3). doi:10.25135/org.2606.3946
BibTeX
@article{Yawale2026,
author = {Yawale, Prashant Rameshwarrao and Humne, Vivek Tukaramji and Jadhao, Nitin Lalsing and Thakare, Nilesh Ramdas},
title = {Design, synthesis and biological evaluation of novel N-napthyl-5-aryl-1,3,4-thiadiazol-2-amine derivatives as anticancer and their molecular docking studies},
journal = {Organic Communications},
year = {2026},
volume = {19},
number = {3},
doi = {10.25135/org.2606.3946}
}
EUVIMED